Evidence map›Paper›PMID 39948090›Full record

ArticleNature communications2025

Phages carry orphan antitoxin-like enzymes to neutralize the DarTG1 toxin-antitoxin defense system.

Anna Johannesman, Leila C Awasthi, Nico Carlson, Michele LeRoux

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. How bacterial immune systems sense phage infection.Nature reviews. Microbiology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Linear-time prediction of proteome-scale microbial protein interactions.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Anna JohannesmanDepartment of Molecular Microbiology, Washington University in Saint Louis School of Medicine, Saint Louis, MO, USA.
Leila C AwasthiDepartment of Molecular Microbiology, Washington University in Saint Louis School of Medicine, Saint Louis, MO, USA.
Nico CarlsonDepartment of Molecular Microbiology, Washington University in Saint Louis School of Medicine, Saint Louis, MO, USA.
Michele LeRouxDepartment of Molecular Microbiology, Washington University in Saint Louis School of Medicine, Saint Louis, MO, USA. mleroux@wustl.edu.ORCID http://orcid.org/0000-0003-2075-4208

Funding

Mining the phage playbook to create a potent, generic phage therapyDP2AI177955 · NIAID · WASHINGTON UNIVERSITY · PI Michele LeRoux · 2023 to 2026
$1.9M
NIAID NIH HHS DP2 AI177955
6 · The paper itself

Abstract

The astounding number of anti-phage defenses encoded by bacteria is countered by an elaborate set of phage counter-defenses, though their evolutionary origins are often unknown. Here, we report the discovery of an orphan antitoxin counter-defense element in T4-like phages that can overcome the bacterial toxin-antitoxin phage defense system, DarTG1. The DarT1 toxin, an ADP-ribosyltransferase, modifies phage DNA to prevent replication while its cognate antitoxin, DarG1, is a NADAR superfamily ADP-ribosylglycohydrolase that reverses these modifications in uninfected bacteria. We show that some phages carry an orphan DarG1-like NADAR domain protein, which we term anti-DarT factor NADAR (AdfN), that removes ADP-ribose modifications from phage DNA during infection thereby enabling replication in DarTG1-containing bacteria. We find divergent NADAR proteins in unrelated phages that likewise exhibit anti-DarTG1 activity, underscoring the importance of ADP-ribosylation in bacterial-phage interactions, and revealing the function of a substantial subset of the NADAR superfamily.

Indexed as

ADP Ribose TransferasesAntitoxinsBacterial ToxinsBacteriophagesToxin-Antitoxin SystemsViral ProteinsADP-RibosylationBacterial ProteinsDNA, ViralADP Ribose TransferasesAntitoxinsBacterial ProteinsBacterial ToxinsDNA, ViralViral Proteins

Identifiers

PMID39948090
PMCPMC11825919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.